Gilead Sciences, Inc. Total Debt 2007–2025
Gilead Sciences, Inc. reported $27.74B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 2.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -18.8%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $27.74B | -2.7% |
| FY 2024 | $28.52B | +6.5% |
| FY 2023 | $26.79B | -2.6% |
| FY 2022 | $27.50B | -2.5% |
| FY 2021 | $28.21B | -17.4% |
| FY 2020 | $34.16B | +38.9% |
| FY 2019 | $24.59B | -10.0% |
| FY 2018 | $27.32B | -24.7% |
| FY 2017 | $36.29B | +37.7% |
| FY 2016 | $26.35B | +13.8% |
| FY 2015 | $23.16B | +79.7% |
| FY 2014 | $12.89B | +38.1% |
| FY 2013 | $9.33B | -0.6% |
| FY 2012 | $9.39B | +23.5% |
| FY 2011 | $7.61B | +1077.0% |
| FY 2010 | $646.35M | +11468.7% |
| FY 2009 | $5.59M | -0.8% |
| FY 2008 | $5.63M | — |
| FY 2007 | $0 | — |
Source: Gilead Sciences, Inc. SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open GILD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Gilead Sciences, Inc. reported $27.74B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 2.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -18.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Gilead Sciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeGilead Sciences, Inc. — frequently asked questions
What is Gilead Sciences, Inc.'s total debt (short- plus long-term borrowings)?
Gilead Sciences, Inc. (GILD) reported total debt (short- plus long-term borrowings) of $27.74B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Gilead Sciences, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More GILD financial history
Full GILD fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →